A carregar...
4CPS-085 Assessment of the direct-acting antivirals used to treat the hepatitis c virus genotype 4 infection in a tertiary hospital
BACKGROUND: Hepatitis C is a serious disease with high prevalence, being the leading cause of liver transplantation. The development of well-tolerated and highly-effective direct acting antivirals (DAAs) for hepatitis C virus (HCV) has dramatically changed the therapeutic landscape PURPOSE: Assessin...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535498/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.176 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|